All News

Retail pharmacists are ideally situated to perform MTM through collaborative agreements with physicians, and some are making it happen.

The Food and Drug Administration (FDA) has released its lists of approved biosimilar licensed products, called the “Purple Book”. The invaluable site includes the date a biological product was licensed under the PHS Act and whether FDA evaluated the biological product for reference product exclusivity.

As part of its restructuring plan, Walgreens Boots Alliance announced April 9 that it plans to close about 200 of its less-profitable stores throughout the United States.

The urge to amass wealth is a great motivator in the making and selling of commodities. But for delivery of healthcare services? Maybe not so much.

Approximately one third of U.S. hospitals have completely migrated to the electronic health record (EHR) and are no longer using paper charts. In those hospitals with an EHR that they use completely or in combination with paper charts, 80% give pharmacists the ability to make recommendations and document them in the EHR.

The mission of this peer-reviewed journal is to offer a forum for pharmacists to share their research and quality improvement projects from their residency training in an effort to advance patient care and optimize medication use.

Target Canada Co. announced that it will close all its 133 Canadian retail locations on April 12, completing its inventory liquidation, according to a company statement.

Recently, state legislators in Colorado passed a biosimilars bill that would allow pharmacists to substitute a biosimilar drug for name-brand biologics in cases where the FDA has declared the drugs interchangeable.

Experts provided advice on the implementation of AB 1535, the California law that allows pharmacists to furnish naloxone in California without a prescription, during a recent webinar hosted by the California Pharmacists Association.